Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
作者： Johann S. de Bono , Howard I. Scher , R. Bruce Montgomery , Christopher Parker , M. Craig Miller
DOI: 10.1158/1078-0432.CCR-08-0872
关键词:
摘要: … Assessment of circulating tumor cells (CTC) using CellSearch has been cleared by the Food and Drug Administration as a prognostic indicator for patients with metastatic breast, …
elsevier.com
utwente.nl
narcis.nl
aacrjournals.org参考文章(23)
Stuart G Baker, Barnett S Kramer, A perfect correlate does not a surrogate make. BMC Medical Research Methodology. ,vol. 3, pp. 16- 16 ,(2003) , 10.1186/1471-2288-3-16
Howard I. Scher, Mary Warren, Glenn Heller, The Association Between Measures of Progression and Survival in Castrate-Metastatic Prostate Cancer Clinical Cancer Research. ,vol. 13, pp. 1488- 1492 ,(2007) , 10.1158/1078-0432.CCR-06-1885
Tomasz Burzykowski, Marc Buyse, Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation. Pharmaceutical Statistics. ,vol. 5, pp. 173- 186 ,(2006) , 10.1002/PST.207
Howard I. Scher, Charles L. Sawyers, Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis Journal of Clinical Oncology. ,vol. 23, pp. 8253- 8261 ,(2005) , 10.1200/JCO.2005.03.4777
G Attard, D Sarker, A Reid, R Molife, C Parker, J S de Bono, Improving the outcome of patients with castration-resistant prostate cancer through rational drug development British Journal of Cancer. ,vol. 95, pp. 767- 774 ,(2006) , 10.1038/SJ.BJC.6603223
Daniel C. Danila, Glenn Heller, Gretchen A. Gignac, Rita Gonzalez-Espinoza, Aseem Anand, Erika Tanaka, Hans Lilja, Lawrence Schwartz, Steven Larson, Martin Fleisher, Howard I. Scher, Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer Clinical Cancer Research. ,vol. 13, pp. 7053- 7058 ,(2007) , 10.1158/1078-0432.CCR-07-1506
Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, Alison Stopeck, Jeri Matera, M. Craig Miller, James M. Reuben, Gerald V. Doyle, W. Jeffrey Allard, Leon W.M.M. Terstappen, Daniel F. Hayes, Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer The New England Journal of Medicine. ,vol. 351, pp. 781- 791 ,(2004) , 10.1056/NEJMOA040766
Laurence Collette, Tomasz Burzykowski, Kevin J. Carroll, Don Newling, Tom Morris, Fritz H. Schröder, Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals Journal of Clinical Oncology. ,vol. 23, pp. 6139- 6148 ,(2005) , 10.1200/JCO.2005.08.156
W. Jeffrey Allard, Jeri Matera, M. Craig Miller, Madeline Repollet, Mark C. Connelly, Chandra Rao, Arjan G. J. Tibbe, Jonathan W. Uhr, Leon W. M. M. Terstappen, Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research. ,vol. 10, pp. 6897- 6904 ,(2004) , 10.1158/1078-0432.CCR-04-0378
G. Thomas Budd, Massimo Cristofanilli, Mathew J. Ellis, Allison Stopeck, Ernest Borden, M. Craig Miller, Jeri Matera, Madeline Repollet, Gerald V. Doyle, Leon W.M.M. Terstappen, Daniel F. Hayes, Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer Clinical Cancer Research. ,vol. 12, pp. 6403- 6409 ,(2006) , 10.1158/1078-0432.CCR-05-1769